Sequential Natalizumab–Alemtuzumab Therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS)
ClinicalTrials.gov Identifier: NCT03135249
Cladribine Tablets after treatment with natalizumab (CLADRINA)
ClinicalTrials.gov Identifier: NCT04178005
CLadribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous
System BiomarKers in Multiple Sclerosis (CLOCK-MS)
ClinicalTrials.gov Identifier: NCT03963375
Lipoic acid for Treatment of Progressive Multiple Sclerosis. (LAPMS)
ClinicalTrials.gov Identifier: NCT03161028
Mitochondrial capacity boost in ALS (MICABO-ALS) trial.
ClinicalTrials.gov Identifier: NCT04244630